WallStSmart
JUNS

Jupiter Neurosciences, Inc. Common Stock

NASDAQ: JUNS · HEALTHCARE · BIOTECHNOLOGY

$0.38
+5.33% today

Updated 2026-04-30

Market cap
$13.16M
P/E ratio
P/S ratio
603.58x
EPS (TTM)
$-0.25
Dividend yield
52W range
$0 – $3
Volume
0.1M

Jupiter Neurosciences, Inc. Common Stock (JUNS) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-4.1%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-49.6%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-0.8%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-5.1%
2026-02-25
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-25$-0.07-24.7%$0.60$0.57-5.1%
2025-12-03$-0.07+12.5%$1.18$1.22+3.4%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.06$-0.07-24.7%$21796.00
2025-09-30$-0.08$-0.07+12.5%
2025-06-30$-0.07$-0.07+0.0%
2025-03-31$-0.03$-0.05-66.7%
2024-12-31$-0.02$-0.05-150.0%
2024-09-30$-0.02$-0.02+0.0%
2021-12-31$0.00$-0.07
2021-09-30$0.00$-0.03

Frequently asked questions

Has Jupiter Neurosciences, Inc. Common Stock beaten earnings estimates?
Jupiter Neurosciences, Inc. Common Stock has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -4.1% over the last 3 quarters.
How does JUNS stock react to earnings?
JUNS stock has moved an average of -0.8% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.